CABA

Cabaletta Bio, Inc.

Biotechnology · Biotechnology

$163.60 sample

-0.97 (-0.59%) 1D

Market cap

$200.4B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-23

Alerts

8

Price$163.60 -1.27% 3M daily closessample

178.83158.31

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: 10% owner
Sep 23SEC8-K filed: material event
Sep 15INSInsider sell: Chief Executive Officer
Sep 07INSInsider buy: 10% owner
Aug 27INSInsider sell: Director
Aug 20INSInsider buy: General Counsel
Aug 13SECForm 144 filed
Aug 10INSInsider sell: Chief Executive Officer

Sign up to see the real CABA record →

Company facts

SEC EDGAR registration

Name: Cabaletta Bio, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -17sample, -100 to +100
Reporting currency: USD

Who is positioning in CABA

sample

Insiders: 28 insider transactions over 90 days, net selling, $478.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 44 funds hold $4.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.3B +9.1% y/y

Q4 2024Q3 2026

Inventory$7.0B +15.1% y/y

Q4 2024Q3 2026

Accounts receivable$5.4B +22.5% y/y

Q4 2024Q3 2026

Total debt$13.3B +10.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $99.2B -11.4% 3M
Sample peer B: $94.6B -11.4% 3M
Sample peer C: $51.0B +14.4% 3M
Sample peer D: $31.3B -0.5% 3M
Sample peer E: $198.9B +1.1% 3M